We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Gastric Fluids Could Help Power Ingestible Devices

By HospiMedica International staff writers
Posted on 21 Feb 2017
A new study suggests that electrolytes in gastric acid could provide a sufficiently potent energy source to power ingestible electronics.

Researchers at Brigham and Women’s Hospital, the Massachusetts Institute of Technology, and other institutions have developed a prototype ingestible capsule body temperature monitor that is powered by an energy-harvesting galvanic cell, based on a redox couple formed by a dissolving metallic anode that undergoes galvanic oxidation, and an inert cathode that returns electrons to the gastrointestinal (GI) fluids that form the electrolyte.

The bio-galvanic cell delivered an average power of 0.23 μW mm−2 of electrode area for an average of 6.1 days of temperature measurements in the GI tract of pigs, with measurements taken every 12 seconds, on average, and sent wirelessly to a remote device. More...
In addition, the researchers showed that prototype devices could activate the release of fluids contained within the device using the harvested power, illustrating potential therapeutic applications for drug delivery. The study was published on February 6, 2017, in Nature Biomedical Engineering.

“Because of the GI tract's unique position in the body - adjacent to the heart, lungs, and liver - there is a growing interest in devices that can also monitor and potentially treat a variety of organ systems and conditions,” said senior author gastroenterologist and biomedical engineer C. Giovanni Traverso, MD, PhD, of the BWH division of gastroenterology. “The future of ingestible devices could look dramatically different from what we have today. Ingestible electronics have an expanding role in the evaluation of patients.”

“The potential of applying electronics or electrical signals for treatment is being explored and the potential for long-term monitoring and treatment is being realized through the development of systems with the capacity for safe, extended gastrointestinal residence,” concluded Dr. Traverso and colleagues. “Energy alternatives for GI systems are needed to enable broad applicability, especially given size and biocompatibility constraints coupled with the need for long-term power sources and low-cost systems.”


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Multifunctional Patient Floor Lift
Maxi Move 5
New
Ultra-Low Temperature Freezer
iUF118-GX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.